Trinity Partners will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston.

Trinity Partners, a leading global life sciences consulting firm, today announced it will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston. Trinity’s Krista Perry will be presenting at the conference to highlight Trinity’s continued involvement supporting companies commercializing products for rare diseases, including our significant experience with gene and cell therapies. With Trinity as a key sponsor, this event brings together 450+ industry leaders and experts from innovative biotechs, large pharma, academia and key service provider companies to provide the latest and a comprehensive insight into the impact of gene therapy today and its evolution in the future. Additional Trinity members in attendance will include Christian Frois, Blair Miller, Rachel Halperin, and Mahaney Sippel. http://bit.ly/gtherap

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s